Cenobamate (ONTOZRY®), for the treatment of uncontrolled focal-onset seizures in adults, is now available in 5 major European countries – Germany, the UK, Italy, Spain, France – and 10 other key markets PANGYO, South Korea, Dec. 9, 2022 /PRNewswire/ SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an international pharmaceutical company.
SK Biopharmaceuticals Partner Angelini Pharma Launches Cenobamate in France streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SK Biopharmaceuticals Partner Angelini Pharma Launches Cenobamate in France businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an international.